Serum resistin levels are associated with adiposity and insulin sensitivity in obese hispanic subjects

Metabolic Syndrome and Related Disorders

Volumn 12, Issue 2, 2014, Pages 143-148

  Nieva Vazquez, Adriana ^a,b,c   Pérez Fuentes, Ricardo ^a,c   Torres Rasgado, Enrique ^a,b   López López, José G ^a   Romero, Jose R ^b  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSITY; ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HISPANIC AMERICANS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; RESISTIN; YOUNG ADULT;

EID: 84894434562     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2013.0118     Document Type: Article

References (43)

1. Steppan CM, Lazar MA. Resistin and obesity-Associated insulin resistance. Trends Endocrinol Metab 2002;13:18-23
2. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307-312
3. Kim KH, Lee K, Moon YS, et al. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001;276:11252-11256
4. Holcomb IN, Kabakoff RC, Chan B, et al. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 2000; 19:4046-4055
5. Steppan CM, Brown EJ, Wright CM, et al. A family of tissuespecific resistin-like molecules. Proc Natl Acad Sci USA 2001;98:502-506
6. Sentinelli F, Romeo S, Arca M, et al. Human resistin gene, obesity and type 2 diabetes: Mutation analysis and population study. Diabetes 2002;51:860-862
7. Asano H, Izawa H, Nagata K, et al. Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. Diabetologia 2010;53:234-246
8. Rajala MW, Qi Y, Patel HR, et al. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 2004;53:1671-1679
9. McTernan CL, McTernan PG, Harte AL, et al. Resistin, central obesity, and type 2 diabetes. Lancet 2002;359:46-47
10. McTernan PG, McTernan CL, Chetty R, et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 2002;87:2407-2410
11. Heilbronn LK, Rood J, Janderova L, et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 2004;89:1844-1848
12. Vendrell J, Broch M, Vilarrasa N, et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: Relationships in obesity. Obes Res 2004;12:962-971
13. Schaffler A, Buchler C, Muller-Ladner U, et al. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Horm Metab Res 2004; 36:702-707
14. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 2003;88:5452-5455
15. Azuma K, Katsukawa F, Oguchi S, et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 2003;11:997-1001
16. Vozarova de Courten B, Degawa-Yamauchi M, Considine RV, et al. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes 2004;53:1279-1284
17. Yannakoulia M, Yiannakouris N, Bluher S, et al. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 2003;88:1730-1736
18. Menzaghi C, Coco A, Salvemini L, et al. Heritability of serum resistin and its genetic correlation with insulin resistancerelated features in nondiabetic Caucasians. J Clin Endocrinol Metab 2006;91:2792-2795
19. Silha JV, Krsek M, Skrha JV, et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: Correlations with insulin resistance. Eur J Endocrinol 2003;149: 331-335
20. De Luis DA, Terroba MC, Cuellar L, et al. Resistin levels in morbid obese patients following the biliopancreatic diversion surgery. Horm Metab Res 2011;43:205-208
21. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;l27:1487-1495
22. Ebong IA, Goff DC, Rodriguez CJ, et al. Association of lipids with incident heart failure among adults with and without diabetes mellitus: Multiethnic study of atherosclerosis. Circulation: Heart Failure 2013;6:371-378
23. Boizel R, Yves-Benhamou P, Lardy B, et al. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care 2000;23:1679-1685
24. Gonzalez-Chavez A, Amancio-Chassin O, Islas-Andrade S, et al. Cardiovascular risk factors associated to abdominal obesity in apparently healthy subjects. Rev Med Inst Mex Seguro Soc 2008;46:273-279
25. Hrebicek J, Janout V, Malincikova J, et al. Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 2002;87:144-147
26. Muniyappa R, Lee S, Chen H. Current approaches for assessing insulin sensitivity and appropriate usage resistance in vivo: Advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008;294:15-26
27. Owecki M, Miczke A, Nikisch E, et al. Serum resistin concentrations are higher in human obesity but independent from insulin resistance. Exp Clin Endocrinol Diabetes 2011; 119:117-121
28. Lee JH, Chan JL, Yiannakouris N, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: Cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 2003;88:4848-4856
29. Won JC, Park CY, Lee WY, et al. Association of plasma levels of resistin with subcutaneous fat mass and markers of inflammation but not with metabolic determinants or insulin resistance. J Korean Med Sci 2009;24:695-700
30. Ikeda Y, Tsuchiya H, Hama S, et al. Resistin affects lipid metabolism during adipocyte maturation of 3T3-L1 cells. FEBS J 2013:1-12
31. Kosari S, Camera DM, Hawley JA, et al. ERK1/2 in the brain mediates the effects of central resistin on reducing thermogenesis in brown adipose tissue. Int J Physiol Pathophysiol Pharmacol 2013;5:184-189
32. Jamaluddin MS, Weakley SM, Yao Q, et al. Resistin: Functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol 2012;165:622-632
33. Bokarewa M, Nagaev I, Dahlberg L, et al. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005;174:5789-5795
34. Nagaev I, Bokarewa M, Tarkowski A, et al. Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS One 2006;1:31
35. Bostrom E.A, Tarkowski A, Bokarewa M. Resistin is stored in neutrophil granules being released upon challenge with inflammatory stimuli. Biochim Biophys Acta;2009;1793:1894-1900
36. Osawa H, Tabara Y, Kawamoto R, et al. Plasma resistin, associated with single nucleotide polymorphism - 420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C reactive protein in the Japanese general population. Diabetes Care 2007;30:1501-1506
37. Chen BH, Song Y, Ding EL, et al. Association of resistin promoter polymorphisms with plasma resistin levels and type 2 diabetes in women and men. Int J Mol Epidemiol Genet 2010;1:167-174
38. Fargnoli JL, Sun Q, Olenczuk D, et al. Resistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function. Eur J Endocrinol 2010;162:281-288
39. Iqbal N, Seshadri P, Stern L, et al. Serum resistin is not associated with obesity or insulin resistance in humans. Eur Rev Med Pharmacol Sci 2005;9:161-165
40. Steppan CM, Lazar MA. The current biology of resistin. J Intern Med, 2004;255:439-447
41. Hivert MF, Sullivan LM, Fox CS, et al. Associations of adiponectin, resistin, and tumor necrosis factor-Alpha with insulin resistance. J Clin Endocrinol Metab 2008;93:3165-3172
42. Pischon T, Bamberger CM, Kratzsch J, et al. Association of plasma resistin levels with coronary heart disease in women. Obes Res 2005;13:1764-1771
43. Chen BH, Song Y, Ding EL, et al. Circulating levels of resistin and risk of type 2 diabetes in men and women: Results from two prospective cohorts. Diabetes Care 2009;32:329-334